StonvexLoading…
StonvexStonvexStonvexCore line items from INTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $504.12M | $430.52M | $350.87M | $272.07M |
Operating Income | $-27.36M | $-32.19M | $-69.26M | $-99.46M |
Net Income | $-18.22M | $-32.02M | $-69.42M | $-99.68M |
EPS (Diluted) | $-0.23 | $-0.45 | $-1.08 | $-1.63 |
Total Assets | $894.16M | $733.00M | $628.91M | $494.41M |
Total Liabilities | $374.40M | $329.76M | $287.70M | $238.53M |
Cash & Equivalents | $313.11M | $208.37M | $130.38M | $50.78M |
Free Cash Flow OCF − CapEx | $121.86M | $64.77M | $25.27M | $13.68M |
Shares Outstanding | 81.88M | 74.62M | 68.57M | 62.74M |